Ceftriaxone-Induced Immune Hemolytic Anemia: In Vitro Reversal with Peptide Inhibitor of Complement C1 (PIC1)

Autor: Cunnion, Kenji M., Feagin, Lisa M., Chicella, Michael F., Kaszowski, Cortney L., Hair, Pamela S., Price, Jessica, Owen, William C.

Publikováno v: Case Reports in Hematology.

We report a case of ceftriaxone-induced immune hemolytic anemia in a 10-year-old with chronic active Epstein–Barr virus disease and hemophagocytic lymphohistiocytosis. After chemotherapy, she became febrile and received ceftriaxone. She rapidly dev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=hindawi_publ::66b417ff169680969d419b4773f68180

Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients.

Autor: Chicella, Michael, Jansen, Paul, Parthiban, Anitha, Marlowe, Karen F, Bencsath, F Aladar, Krueger, Kem P, Boerth, Robert

Publikováno v: Critical Care Medicine; 2002 Dec, Vol. 30 Issue 12, p2752-2756, 5p

Prokinetic Drug Therapy in Children: A Review of Current Options

Autor: Chicella, Michael F, Batres, L Arturo, Heesters, Michael S, Dice, James E

Publikováno v: The Annals of Pharmacotherapy; April 2005, Vol. 39 Issue: 4 p706-711, 6p

Clinical pharmacists: Essential members of the pediatric critical care team.

Autor: Chicella, Michael F.¹ chicelmf@chkd.org, Dice, James E.¹

Publikováno v: American Journal of Health-System Pharmacy. 9/1/2005, Vol. 62 Issue 17, p1763. 1p.

Improving Palivizumab Compliance rough a Pharmacist-Managed RSV Prevention Clinic.

Autor: Chow JW; Department of Pharmacy (JWC, MFC, JED), Children's Hospital of The King's Daughters, Norfolk, Virginia, Department of Pediatrics (MFC, CSM, JH), Eastern Virginia Medical School, Norfolk, Virginia, Department of Pharmaceutical Services (AMC), St. Jude Children's Research Hospital, Memphis, Tennessee., Chicella MF; Department of Pharmacy (JWC, MFC, JED), Children's Hospital of The King's Daughters, Norfolk, Virginia, Department of Pediatrics (MFC, CSM, JH), Eastern Virginia Medical School, Norfolk, Virginia, Department of Pharmaceutical Services (AMC), St. Jude Children's Research Hospital, Memphis, Tennessee., Christensen AM; Department of Pharmacy (JWC, MFC, JED), Children's Hospital of The King's Daughters, Norfolk, Virginia, Department of Pediatrics (MFC, CSM, JH), Eastern Virginia Medical School, Norfolk, Virginia, Department of Pharmaceutical Services (AMC), St. Jude Children's Research Hospital, Memphis, Tennessee., Moneymaker CS; Department of Pharmacy (JWC, MFC, JED), Children's Hospital of The King's Daughters, Norfolk, Virginia, Department of Pediatrics (MFC, CSM, JH), Eastern Virginia Medical School, Norfolk, Virginia, Department of Pharmaceutical Services (AMC), St. Jude Children's Research Hospital, Memphis, Tennessee., Harrington J; Department of Pharmacy (JWC, MFC, JED), Children's Hospital of The King's Daughters, Norfolk, Virginia, Department of Pediatrics (MFC, CSM, JH), Eastern Virginia Medical School, Norfolk, Virginia, Department of Pharmaceutical Services (AMC), St. Jude Children's Research Hospital, Memphis, Tennessee., Dice JE; Department of Pharmacy (JWC, MFC, JED), Children's Hospital of The King's Daughters, Norfolk, Virginia, Department of Pediatrics (MFC, CSM, JH), Eastern Virginia Medical School, Norfolk, Virginia, Department of Pharmaceutical Services (AMC), St. Jude Children's Research Hospital, Memphis, Tennessee.

Publikováno v: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG [J Pediatr Pharmacol Ther] 2017 Sep-Oct; Vol. 22 (5), pp. 338-343.